# New Strategies to Assess Anal Cancer Risk In Women

> **NCT02873741** · — · COMPLETED · sponsor: **Emory University** · enrollment: 143 (actual)

## Conditions studied

- Human Immunodeficiency Virus (HIV)
- Human Papillomavirus (HPV)

## Interventions

- **PROCEDURE:** Perianal and Digital Anorectal Exam
- **PROCEDURE:** Cervical Swabs
- **PROCEDURE:** Anal Swabs
- **PROCEDURE:** High Resolution Anoscopy (HRA)

## Key facts

- **NCT ID:** NCT02873741
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2017-02-27
- **Final completion:** 2017-02-27
- **Target enrollment:** 143 (ACTUAL)
- **Last updated:** 2019-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02873741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02873741, "New Strategies to Assess Anal Cancer Risk In Women". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT02873741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*